Skip to main navigation Skip to search Skip to main content

A 40-week phase 2B randomized, multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosis

  • the Neuromuscular Study Group and Western ALS Consortium Memantine ALS Study Group

Research output: Contribution to journal › Article › peer-review

7   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'A 40-week phase 2B randomized, multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosis'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience